Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

JAGX Jaguar Health Inc

-0.0985 (-38.10%)
May 20 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 64,940,322
Bid Price 0.1542
Ask Price 0.16
News -
Day High 0.1739


52 Week Range


Day Low 0.14
Company Name Stock Ticker Symbol Market Type
Jaguar Health Inc JAGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0985 -38.10% 0.16 19:59:32
Open Price Low Price High Price Close Price Prev Close
0.16 0.14 0.1739 0.1686 0.2585
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
49,704 64,940,322 $ 0.1568613 $ 10,186,623 - 0.0512 - 0.75
Last Trade Time Type Quantity Stock Price Currency
19:59:32 formt 300 $ 0.16 USD

Jaguar Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.63M 50.76M - 9.76M -41.3M -0.81 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jaguar Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No JAGX Message Board. Create One! See More Posts on JAGX Message Board See More Message Board Posts

Historical JAGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.28550.33490.140.271643239,637,845-0.1255-43.96%
1 Month0.16990.360.140.256780959,522,678-0.0099-5.83%
3 Months0.06140.360.0560.155394274,479,1490.0986160.59%
6 Months0.42540.51440.05120.151653641,464,285-0.2654-62.39%
1 Year0.6590.750.05120.164869821,876,895-0.499-75.72%
3 Years89.25228.000.051217.5710,308,585-89.09-99.82%
5 Years1,076.251,273.500.051261.8010,425,013-1,076.09-99.99%

Jaguar Health Description

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

Your Recent History

Delayed Upgrade Clock